This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nusse, R Articles by van Ooyen, A Search for Related Content PubMed PubMed Citation Articles by Nusse, R Articles by van Ooyen, A

 Previous Article  |  Next Article 

Mol Cell Biol. 1990 August; 10(8): 4170-4179

The Wnt-1 (int-1) oncogene promoter and its mechanism of activation by insertion of proviral DNA of the mouse mammary tumor virus.

R Nusse, H Theunissen, E Wagenaar, F Rijsewijk, A Gennissen, A Otte, E Schuuring and A van Ooyen

Division of Molecular Biology, The Netherlands Cancer Institute, Amsterdam.

ABSTRACT

Wnt-1 (int-1) is a cellular oncogene often activated by insertion of proviral DNA of the mouse mammary tumor virus. We have mapped the 5' end and the promoter area of the Wnt-1 gene by nuclease protection and primer extension assays. In differentiating P19 embryonal carcinoma cells, in which Wnt-1 is naturally expressed, two start sites of transcription were found, one preceded by two TATA boxes and one preceded by several GC boxes. In P19 cells, a 1-kilobase upstream sequence of Wnt-1 was able to confer differentiation-specific expression on a heterologous gene. We have investigated how Wnt-1 transcription was affected by mouse mammary tumor virus proviral integrations in various configurations near the promoters of the gene. One provirus has been inserted in the 5' nontranslated part of Wnt-1, in the same transcriptional orientation, and has functionally replaced the Wnt-1 promoters. Wnt-1 transcription in this tumor starts in the right long terminal repeat of the provirus, with considerable readthrough transcription from the left long terminal repeat. Another provirus has been inserted in the orientation opposite that of Wnt-1 into a GC box, disrupting the first Wnt-1 transcription start site but not the downstream start site. Most insertions have not structurally altered the Wnt-1 transcripts and have enhanced the activity of the normal two promoters.

---

Mol Cell Biol. 1990 August; 10(8): 4170-4179

This article has been cited by other articles:

• Cardiff, R. D., Rosner, A., Hogarth, M. A., Galvez, J. J., Borowsky, A. D., Gregg, J. P. (2004). Validation: The New Challenge for Pathology. Toxicol Pathol 32: 31-39 [Abstract]  
• van Gijn, M. E., Daemen, M. J.A.P., Smits, J. F.M., Blankesteijn, W.M. (2002). The wnt-frizzled cascade in cardiovascular disease. Cardiovasc Res 55: 16-24 [Full Text]  
• Horikawa, I., Cable, P. L., Afshari, C., Barrett, J. C. (1999). Cloning and Characterization of the Promoter Region of Human Telomerase Reverse Transcriptase Gene. Cancer Res. 59: 826-830 [Abstract] [Full Text]  
• Lessing, D, Nusse, R (1998). Expression of wingless in the Drosophila embryo: a conserved cis-acting element lacking conserved Ci-binding sites is required for patched-mediated repression. Development 125: 1469-1476 [Abstract]  
• Echelard, Y, Vassileva, G, McMahon, A. (1994). Cis-acting regulatory sequences governing Wnt-1 expression in the developing mouse CNS. Development 120: 2213-2224 [Abstract]  
• Dickinson, M., Krumlauf, R, McMahon, A. (1994). Evidence for a mitogenic effect of Wnt-1 in the developing mammalian central nervous system. Development 120: 1453-1471 [Abstract]  
• Song, D. H., Sussman, D. J., Seldin, D. C. (2000). Endogenous Protein Kinase CK2 Participates in Wnt Signaling in Mammary Epithelial Cells. J. Biol. Chem. 275: 23790-23797 [Abstract] [Full Text]